Nanz Med Science Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 6.04 Cr
as on 16-11-2024
- Company Age 18 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 90.72 Cr
as on 16-11-2024
- Satisfied Charges ₹ 46.50 Cr
as on 16-11-2024
- Revenue 18.83%
(FY 2023)
- Profit 5.34%
(FY 2023)
- Ebitda 3.26%
(FY 2023)
- Net Worth 7.39%
(FY 2023)
- Total Assets 16.53%
(FY 2023)
About Nanz Med Science Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 6.04 Cr.
The company currently has active open charges totaling ₹90.72 Cr. The company has closed loans amounting to ₹46.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Nanz Med Science Pharma Private Limited India is Shrishty Kumari as COMPANY SECRETARY. Lakhvinder Singh and Manmit Malhotra serve as directors at the Company.
- CIN/LLPIN
U24100DL2006PTC156756
- Company No.
156756
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nanz Med Science Pharma Private Limited offer?
Nanz Med Science Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Hand Sanitizer & Disinfectant, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Anti-Itch Skin Cream.
Who are the key members and board of directors at Nanz Med Science Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manmit Malhotra  | Managing Director | 01-Apr-2009 | Current |
| Shrishty Kumari | Company Secretary | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakhvinder Singh  | Director | 01-Oct-2007 | Current |
Financial Performance of Nanz Med Science Pharma.
Nanz Med Science Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.83% increase. The company also saw a slight improvement in profitability, with a 5.34% increase in profit. The company's net worth moved up by a moderate rise of 7.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nanz Med Science Pharma?
In 2023, Nanz Med Science Pharma had a public holding of 13.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glide Chem Private LimitedActive 26 years 7 monthsLakhvinder Singh and Manmit Malhotra are mutual person
- Nanz Healthcare Private LimitedActive 4 years 5 months
Lakhvinder Singh and Manmit Malhotra are mutual person
- Arra Hospitality Group Private LimitedActive 8 years 7 months
Lakhvinder Singh and Manmit Malhotra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Jan 2024 | ₹2.81 M | Open |
Tata Capital Financial Services Limited Creation Date: 18 Dec 2023 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Nov 2023 | ₹4.40 M | Open |
How Many Employees Work at Nanz Med Science Pharma?
Nanz Med Science Pharma has a workforce of 362 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nanz Med Science Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nanz Med Science Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
